Daewoong Pharmaceutical acquires GMP approval from EU for Nabota Factory

Acquiring the cGMP from the U.S. last May and the GMP from the Health Canada, Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabota Factory acquired the EU GMP from the European Medicines Agency(EMA) on the 18^th.

Daewoong Pharmaceutical turned in the marketing authorization application for Nabota at the EMA through the centralized procedure on June 2016, and the application process has been take...